82.48
Delayed Data
As of Apr 09
 +0.86 / +1.05%
Today’s Change
65.25
Today|||52-Week Range
92.64
-9.31%
Year-to-Date
Is AnaptysBio Stock a Buy?
6:06am / MotleyFool.com - Paid Partner Content
Pfizer, Merck, and Eli Lilly Will Pay Their Doctors to Get Back to Treating Patients During the COVID-19 Pandemic
Apr 02 / MotleyFool.com - Paid Partner Content
Merck's Keytruda Receives Priority Review for a Key Indication
Apr 07 / MotleyFool.com - Paid Partner Content